APS03118

Applied Pharmaceutical Science, Inc. · Phase 1 active Small molecule

At a glance

Generic name	APS03118
Also known as	APS03118 administrated orally
Sponsor	Applied Pharmaceutical Science, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of APS03118 in Advanced Solid Tumors Harboring RET Mutations or Fusions (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

APS03118 CI brief — competitive landscape report
APS03118 updates RSS · CI watch RSS
Applied Pharmaceutical Science, Inc. portfolio CI